On-line aptamer affinity solid-phase extraction direct mass spectrometry for the rapid analysis of α-synuclein in blood

Fecha de publicación

2025-03-13T16:52:30Z

2025-03-13T16:52:30Z

2023

2025-03-13T16:52:30Z

Resumen

On-line aptamer affinity solid-phase extraction direct mass spectrometry (AA-SPE-MS) is presented for the rapid purification, preconcentration, and characterization of α-synuclein (α-syn), which is a protein biomarker related to Parkinson's disease. Valve-free AA-SPE-MS is easily implemented using the typical SPE microcartridges and instrumental set-up necessary for on-line aptamer affinity solid-phase extraction capillary electrophoresis-mass spectrometry (AA-SPE-CE-MS). The essential requirement is substituting the application of the separation voltage by a pressure of 100 mbar for mobilization of the eluted protein through the capillary towards the mass spectrometer. Under optimized conditions with recombinant α-syn, repeatability is good in terms of migration time and peak area (percent relative standard deviation (%RSD) values (n = 3) are 1.3 and 6.6% at 1 μg mL−1, respectively). The method is satisfactorily linear between 0.025 and 5 μg mL−1 (R2 > 0.986), and limit of detection (LOD) is 0.02 μg mL−1 (i.e. 1000, 500, and 10 times lower than by CE-MS, direct MS, and AA-SPE-CE-MS, respectively). The established AA-SPE-MS method is further compared with AA-SPE-CE-MS, including for the analysis of α-syn in blood. The comparison discloses the advantages and disadvantages of AA-SPE-MS for the rapid and sensitive targeted analysis of protein biomarkers in biological fluids.

Tipo de documento

Artículo


Versión publicada

Lengua

Inglés

Publicado por

Elsevier B.V.

Documentos relacionados

Versió postprint del document publicat a: https://doi.org/10.1016/j.aca.2023.341149

Analytica Chimica Acta, 2023, vol. 1256, p. 341149

https://doi.org/10.1016/j.aca.2023.341149

Citación recomendada

Esta citación se ha generado automáticamente.

Derechos

cc-by-nc-nd (c) Salim, Hiba et al., 2023

http://creativecommons.org/licenses/by-nc-nd/4.0/